Agilon Health, Inc. (AGL) Downgraded to Sell by Citigroup

Market Context

Agilon Health, Inc. operates in the Healthcare sector. The stock currently trades at $102.68 with a market capitalization of $244.3M.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Citigroup's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Agilon Health, Inc.

Among the 10 most recent ratings: 4 Buy, 5 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Jul 23, 2026	Citigroup	Sell	N/A
Jul 13, 2026	Wells Fargo	Overweight	N/A
May 26, 2026	Barclays	Equal-Weight	N/A
May 21, 2026	Benchmark	Buy	N/A
May 15, 2026	Citigroup	Neutral	N/A

Related Tools: Analyst Ratings Dashboard | View AGL Stock Page